Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-05f108-2026-01-21T09:15:28Z",
    "date": "2026-01-21T09:15:28Z",
    "ocid": "ocds-h6vhtk-05f108",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PLQJ-5727-JCLR",
            "name": "Belfast Health & Social Care Trust",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PLQJ-5727-JCLR"
            },
            "address": {
                "streetAddress": "Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital",
                "locality": "Belfast",
                "postalCode": "BT12 6BA",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKN06"
            },
            "contactPoint": {
                "email": "FinanceProcurement@belfasttrust.hscni.net"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    },
                    {
                        "id": "GB-NIR",
                        "scheme": "UK_CA_DEVOLVED_REGULATIONS",
                        "description": "Northern Irish devolved regulations apply"
                    }
                ]
            }
        },
        {
            "id": "GB-COH-NI041905",
            "name": "ALMAC CLINICAL SERVICES LIMITED",
            "identifier": {
                "scheme": "GB-COH",
                "id": "NI041905"
            },
            "additionalIdentifiers": [
                {
                    "scheme": "GB-PPON",
                    "id": "PRCD-2287-GMQG"
                }
            ],
            "address": {
                "streetAddress": "Almac House",
                "locality": "Craigavon",
                "postalCode": "BT63 5QD",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKN07"
            },
            "contactPoint": {
                "email": "csrfinotifcations@almacgroup.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "url": "http://ww.almacgroup.com",
                "scale": "large",
                "vcse": false,
                "publicServiceMissionOrganization": false,
                "shelteredWorkshop": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PLQJ-5727-JCLR",
        "name": "Belfast Health & Social Care Trust"
    },
    "tender": {
        "id": "DAC20211",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial",
        "description": "This procurement is for the manufacture and testing of over encapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "Schedule 5, (2) The public contract concerns the production of a prototype, or supply of other novel goods or services, for the purpose of (c) other research, experiment, study or development. Age-related macular degeneration (AMD) is a leading cause of visual loss. There are two main forms of AMD: dry and wet. The current wet AMD treatment is intravitreal antiVEGF injections, repeated every 4-12 weeks. Due to the cost of the medication, the route and frequency of administration, this treatment is a significant burden on the NHS budget. An additional treatment option for wet AMD is L-dopa. L-dopa is a widely available drug (used in treatment of Parkinson's), typically in the form of Carbidopa-L-Dopa. It is taken as an oral tablet and is significantly cheaper than the antiVEGF injections. The study will be a placebo-controlled clinical trial. Eligible patients will be randomised to receive either 100mg L-DOPA+25mg carbidopa or placebo twice a day, for 24 months, in addition to the current standard of care to determine if this is a more cost-effective and easier-to-administer treatment regime than the current standard of care. To 'blind' this clinical trial (to reduce bias) requires the development, manufacture and testing of over encapsulated 100mg L-DOPA+25mg carbidopa tablets and development and manufacture of matching placebo capsules. The expertise required to develop and manufacture these capsules in the quantity required for this trial requires outsourcing to a manufacturer licensed by the MHRA possessing the necessary technical expertise.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "prototypesDevelopment"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial",
            "status": "active",
            "value": {
                "amountGross": 593337,
                "amount": 494447.5,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-COH-NI041905",
                    "name": "ALMAC CLINICAL SERVICES LIMITED"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33600000",
                            "description": "Pharmaceutical products"
                        }
                    ],
                    "deliveryAddresses": [
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        },
                        {
                            "region": "UKN",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2026-01-05T00:00:00Z",
                "endDate": "2030-01-05T23:59:59Z"
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "080735-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/080735-2025",
                    "datePublished": "2025-12-08T15:49:01Z",
                    "format": "text/html"
                },
                {
                    "id": "080744-2025",
                    "documentType": "awardNotice",
                    "noticeType": "UK6",
                    "description": "Contract award notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/080744-2025",
                    "datePublished": "2025-12-08T15:58:32Z",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2025-12-18T23:59:59Z",
                    "status": "scheduled"
                }
            ],
            "date": "2025-12-08T00:00:00Z",
            "standstillPeriod": {
                "endDate": "2025-12-17T23:59:59+00:00"
            }
        }
    ],
    "language": "en",
    "contracts": [
        {
            "id": "1",
            "awardID": "1",
            "title": "Manufacture and testing of overencapsulated tablets and placebo capsules for research purposes - LAMDARCT clinical trial",
            "status": "active",
            "period": {
                "startDate": "2026-01-19T00:00:00Z",
                "endDate": "2030-01-05T23:59:59Z"
            },
            "value": {
                "amountGross": 593337,
                "amount": 494447.5,
                "currency": "GBP"
            },
            "aboveThreshold": true,
            "dateSigned": "2026-01-19T00:00:00Z",
            "noAgreedMetricsRationale": "The Contract is below the PS5M threshold for KPI's",
            "documents": [
                {
                    "id": "005092-2026",
                    "documentType": "contractNotice",
                    "noticeType": "UK7",
                    "description": "Contract details notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/005092-2026",
                    "datePublished": "2026-01-21T09:15:28Z",
                    "format": "text/html"
                }
            ]
        }
    ]
}